Dr. Emin Maltepe, a neonatologist at UCSF, combines clinical practice with research in epigenetics and hypoxia. His work focuses on understanding fetal and placental development to address preterm birth complications. As a co-founder of IPD3, he advances pediatric drug and device development, aligning his expertise with Amnion Life’s mission to improve neonatal outcomes.